We are live on ! Find out more
Loomis, Sayles & Company

Loomis, Sayles & Company Portfolio holdings

AUM $74.3B
1-Year Est. Return 24.01%
This Fund
S&P 500
This Quarter Est. Return
+14.84%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$65.3B
AUM Growth
+$7.1B
Cap. Flow
-$1.98B
Cap. Flow %
-3.04%
Top 10 Hldgs %
42.82%
Holding
1,073
New
165
Increased
251
Reduced
511
Closed
103

Sector Composition

Rank Sector Weight
1 Technology 26.98%
2 Communication Services 16.8%
3 Consumer Discretionary 15.29%
4 Healthcare 13.27%
5 Financials 10.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IQV icon
51
IQVIA
IQV
$39.3B
$199M 0.31%
861,997
-72,722
-8% -$14.9M
NKE icon
52
Nike
NKE
$61.9B
$186M 0.29%
1,715,778
-24,388
-1% -$2.62M
CMI icon
53
Cummins
CMI
$88.7B
$168M 0.26%
702,076
-172,584
-20% -$39.2M
MELI icon
54
Mercado Libre
MELI
$92.3B
$162M 0.25%
103,393
-4,729
-4% -$6.7M
GS icon
55
Goldman Sachs
GS
$303B
$158M 0.24%
409,586
-5,899
-1% -$1.97M
ADBE icon
56
Adobe
ADBE
$105B
$158M 0.24%
264,055
-49,317
-16% -$28.4M
FANG icon
57
Diamondback Energy
FANG
$52.7B
$142M 0.22%
917,823
-13,145
-1% -$2.06M
TSM icon
58
TSMC
TSM
$2.18T
$132M 0.2%
1,271,445
-111,607
-8% -$10.6M
WFRD icon
59
Weatherford International
WFRD
$6.22B
$124M 0.19%
1,269,750
+50,362
+4% +$4.68M
TXN icon
60
Texas Instruments
TXN
$261B
$118M 0.18%
694,608
-9,591
-1% -$1.49M
ALNY icon
61
Alnylam Pharmaceuticals
ALNY
$29.3B
$117M 0.18%
608,728
-16,673
-3% -$2.84M
HLNE icon
62
Hamilton Lane
HLNE
$5.57B
$98.8M 0.15%
870,545
-79,320
-8% -$7.5M
AZEK
63
DELISTED
The AZEK Co
AZEK
$95.9M 0.15%
2,507,810
+79,761
+3% +$2.49M
TXRH icon
64
Texas Roadhouse
TXRH
$13.7B
$93.9M 0.14%
767,928
-71,174
-8% -$7.61M
OPCH icon
65
Option Care Health
OPCH
$3.56B
$90.8M 0.14%
2,695,495
-354,046
-12% -$10.9M
TT icon
66
Trane Technologies
TT
$106B
$89.3M 0.14%
366,000
+30,096
+9% +$6.58M
CNMD icon
67
CONMED
CNMD
$1.47B
$88.9M 0.14%
811,601
+22,461
+3% +$2.32M
RMBS icon
68
Rambus
RMBS
$11B
$86.6M 0.13%
1,269,321
-155,060
-11% -$9.66M
P
69
Everpure Inc
P
$29.9B
$86.2M 0.13%
2,418,148
-45,850
-2% -$1.61M
RBC icon
70
RBC Bearings
RBC
$18B
$85.9M 0.13%
301,480
+23,822
+9% +$5.84M
HXL icon
71
Hexcel
HXL
$7.82B
$84.1M 0.13%
1,140,224
-136,800
-11% -$9.25M
MMSI icon
72
Merit Medical Systems
MMSI
$5.32B
$82.1M 0.13%
1,081,000
+49,827
+5% +$3.48M
AXNX
73
DELISTED
Axonics, Inc. Common Stock
AXNX
$81M 0.12%
1,301,360
+48,726
+4% +$2.73M
AEIS icon
74
Advanced Energy
AEIS
$13B
$80.5M 0.12%
739,311
-15,002
-2% -$1.46M
ACA icon
75
Arcosa
ACA
$7.11B
$80.1M 0.12%
969,553
-59,935
-6% -$4.4M

Similar funds

Loomis, Sayles & Company's Q4 2023 Portfolio in Review

As of Q4 2023, Loomis, Sayles & Company held 1,073 positions worth $65.3B, up 12% from $58.2B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Loomis, Sayles & Company withdrew a net $1.98B in Q4 2023, closing 103 positions and reducing 511 holdings. Its most notable exit was Zions Bancorporation, an estimated $86.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Communication Services and Consumer Discretionary.

Against the trend, Loomis, Sayles & Company opened a new position in Vertex worth $37.3M.

  • Loomis, Sayles & Company's largest Q4 2023 buy was Vertex: 1,383,755 shares worth $37.3M.
  • Loomis, Sayles & Company added most to O'Reilly Automotive in Q4 2023, an estimated $103M increase.
  • Loomis, Sayles & Company's biggest Q4 2023 reduction was Bank of America Series L, cutting an estimated $766M.
  • Loomis, Sayles & Company fully exited Zions Bancorporation in Q4 2023, selling an estimated $86.6M.
  • Loomis, Sayles & Company's ten largest holdings make up 43% of its $65.3B portfolio in Q4 2023.
  • Loomis, Sayles & Company opened 165 new positions and closed 103 in Q4 2023.
  • Loomis, Sayles & Company's portfolio value rose 12% quarter-over-quarter to $65.3B.

Based on Loomis, Sayles & Company's 13F filing for Q4 2023, filed 13 Feb 2024.